Scientist.com teams up with VC firm to create marketplace for biotech

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/VasylDolmatov)
(Image: Getty/VasylDolmatov)

Related tags: Scientist.com, Biotech companies

The online marketplace for outsourced R&D services Scientist.com partners with 5AM Ventures to help researchers save time and money – as the industry is "caught between a rock and a hard place," says CEO.

The venture capital (VC) firm specializing in building early-stage biotech companies, 5AM Ventures, co-led an equity investment in Scientist.com in 2017. The company since its foundation in 2002 has raised approximately $1.5bn and invested in 77 companies.

5AM recently launched its "4:59 Initiative," which aims to “jumpstart” seed stage companies with little or no physical lab infrastructure, according to the company. Through its partnership with Scientist.com, these companies now can use the 5AM-branded R&D marketplace to procure outsourced services.

“R&D marketplaces like Scientist.com make it easy for start-up company researchers to connect with experts, design experiments, and then purchase outsourced R&D services on demand,” ​Kevin Lustig, PhD, Scientist.com​ CEO and founder, told us.

The pharmaceutical industry is caught between a rock and a hard place. The industry needs to somehow create more drugs but spend less money doing so,”​ he added.

Lustig said, “R&D marketplaces are the only general solution to this major challenge. Marketplaces allow researchers to save time, save money, access innovation, and ensure compliance with internal and external regulations, all at the same time.”

Since it was founded in 2007, Scientist.com has raised $32m from Leerink Transformation Partners, Heritage Provider Network, 5AM Ventures, and others.

Related news

Related products

show more

The APAC Advantages

The APAC Advantages

Catalent Pharma Solutions | 18-Jan-2022 | Insight Guide

Over recent years, the Asia-Pacific (APAC) region has become an emerging market for pharmaceutical and biotech innovation, including clinical studies.

CellCarta - Mapping Precision Medicine

CellCarta - Mapping Precision Medicine

CellCarta | 17-Jan-2022 | Product Presentation

At CellCarta, we’re dedicated to working with our partners to further the limitless potential of precision medicine. Our broad technology offering is designed...

How a Clinical MDR Helps with Data Quality

How a Clinical MDR Helps with Data Quality

Formedix | 17-Jan-2022 | Technical / White Paper

This article covers the many ways a clinical metadata repository helps with data quality in the clinical trial process, and how it ultimately helps to...

Planning Your Preclinical Assessment

Planning Your Preclinical Assessment

Altasciences | 17-Jan-2022 | Technical / White Paper

There are many challenges associated with early drug discovery and development. Advancing your best candidate for regulatory submissions requires a careful...

Related suppliers

Follow us

Products

View more

Webinars